A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Biofilm 'Life Raft' Changes C. Auris Risk
How Healthcare Restrooms Are Rethinking Water Efficiency
Northwell Health Finds Energy Savings in Steam Systems
The Difference Between Cleaning, Sanitizing and Disinfecting
Jupiter Medical Center Falls Victim to Third-Party Data Breach